Evidence map›Paper›PMID 36404397›Full record

Trial reportEuropean journal of heart failure2023

Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial.

Zachary I Whinnett, Matthew J Shun-Shin, Mark Tanner, Paul Foley, Badri Chandrasekaran, Philip Moore, Shaumik Adhya, Norman Qureshi, Amal Muthumala, Rebecca Lane and 30 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05491655 (High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05491655 narecruitingnot on this map

High Intensity His Bundle Pacing in Heart Failure Patients With Narrow QRS Outcome Study

TypeinterventionalSponsorMiulli General HospitalRan2023 to 2026Enrolled34ConditionsCardiac Conduction System, His Bundle Pacing, Heart Failure, CardiomyopathiesArmsHigh Intensity His Bundle pacing
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Conduction system pacing for cardiac resynchronization therapy: a systematic review.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Physiologic Pacing in Heart Failure.The New England journal of medicine · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. 2024 update in heart failure.ESC heart failure · 2025
    Review
  16. Pacing of the specialized His Purkinje conduction system: 'HOW and FOR WHOM'.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
  17. Review
  18. Conduction System Pacing for CRT: A Physiological Alternative.Arrhythmia & electrophysiology review · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 2 countries.

Zachary I WhinnettNational Heart and Lung Institute, Imperial College London, London, UK.
Matthew J Shun-ShinNational Heart and Lung Institute, Imperial College London, London, UK.
Mark TannerWest Sussex Hospitals NHS Trust, West Sussex, UK.
Paul FoleyGreat Western Hospitals NHS Foundation Trust, Swindon, UK.
Badri ChandrasekaranGreat Western Hospitals NHS Foundation Trust, Swindon, UK.
Philip MooreWest Hertfordshire Hospitals NHS Trust, Hertfordshire, UK.
Shaumik AdhyaMedway NHS Foundation Trust, Kent, UK.
Norman QureshiWycombe General Hospital, High Wycombe, UK.
Amal MuthumalaBarts Health NHS Trust, London, UK.
Rebecca LaneRoyal Brompton and Harefield NHS Trust, London, UK.
Aldo RinaldiGuy's and St. Thomas's NHS Foundation Trust, London, UK.
Sharad AgarwalRoyal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Francisco LeyvaUniversity Hospitals Birmingham, Birmingham, UK.
Jonathan BeharRoyal Brompton and Harefield NHS Trust, London, UK.
Sukh BassiSherwood Forest Hospitals NHS Foundation Trust, UK.
Andre NgDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Paul ScottKings College NHS Hospital, London, UK.
Rachana PrasadKettering General Hospital, Northampton, UK.
Jon SwinburnRoyal Berkshire NHS Foundation Trust, Reading, UK.
Joseph TomsonRoyal Free London Foundation NHS Trust, London, UK.
Amarjit SethiLondon North West University Healthcare NHS Trust, London, UK.
Jaymin ShahLondon North West University Healthcare NHS Trust, London, UK.
Phang Boon LimNational Heart and Lung Institute, Imperial College London, London, UK.
Andreas KyriacouSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dewi ThomasMorriston Hospital Regional Cardiac Centre, Wales, UK.
Jenny ChuenNottingham University Hospitals NHS Trust, Nottingham, UK.
Ravi KamdarCroydon NHS University Hospital, London, UK.
Prapa KanagaratnamNational Heart and Lung Institute, Imperial College London, London, UK.
Myril MarivelesImperial College Healthcare NHS Trust, London, UK.
Leah BurdenImperial College Healthcare NHS Trust, London, UK.
Katherine MarchImperial College Healthcare NHS Trust, London, UK.
James P HowardNational Heart and Lung Institute, Imperial College London, London, UK.
Ahran ArnoldNational Heart and Lung Institute, Imperial College London, London, UK.
Pugazhendhi VijayaramanGeisinger Commonwealth School of Medicine, Geisinger Heart Institute, Scranton, PA, USA.
Berthold StegemannNational Heart and Lung Institute, Imperial College London, London, UK.
Nicholas JohnsonImperial College Trials Unit, Imperial College London, London, UK.
Emanuela FalaschettiImperial College Trials Unit, Imperial College London, London, UK.
Darrel P FrancisNational Heart and Lung Institute, Imperial College London, London, UK.
John G F ClelandSchool of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Daniel KeeneNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-7472-7358
Imperial College Healthcare NHS Trust · GBLung Institute · USBarts Health NHS Trust · GBGreat Western Hospitals NHS Foundation Trust · GBLondon North West Healthcare NHS Trust · GBNIHR Imperial Biomedical Research Centre · GBRoyal Brompton & Harefield NHS Foundation Trust · GBCroydon University Hospital · GBGeisinger Commonwealth School of Medicine · USGuy's and St Thomas' NHS Foundation Trust · GBKettering General Hospital · GBKing's College - North Carolina · USMedway NHS Foundation Trust · GBMorriston Hospital · GBNIHR Surgical Reconstruction and Microbiology Research Centre · GBNottingham University Hospitals NHS Trust · GBPapworth Hospital NHS Foundation Trust · GBRoyal Berkshire NHS Foundation Trust · GBRoyal Free London NHS Foundation Trust · GBSheffield Teaching Hospitals NHS Foundation Trust · GB

Funding

British Heart Foundation CS/15/3/31405British Heart Foundation FS/15/53/31615British Heart Foundation FS/ICRF/22/26039British Heart Foundation Grant/Award Number: CS/15/3/31405
6 · The paper itself

Abstract

aimsExcessive prolongation of PR interval impairs coupling of atrio-ventricular (AV) contraction, which reduces left ventricular pre-load and stroke volume, and worsens symptoms. His bundle pacing allows AV delay shortening while maintaining normal ventricular activation. HOPE-HF evaluated whether AV optimized His pacing is preferable to no-pacing, in a double-blind cross-over fashion, in patients with heart failure, left ventricular ejection fraction (LVEF) ≤40%, PR interval ≥200 ms and either QRS ≤140 ms or right bundle branch block. METHODS AND

resultsPatients had atrial and His bundle leads implanted (and an implantable cardioverter-defibrillator lead if clinically indicated) and were randomized to 6 months of pacing and 6 months of no-pacing utilizing a cross-over design. The primary outcome was peak oxygen uptake during symptom-limited exercise. Quality of life, LVEF and patients' holistic symptomatic preference between arms were secondary outcomes. Overall, 167 patients were randomized: 90% men, 69 ± 10 years, QRS duration 124 ± 26 ms, PR interval 249 ± 59 ms, LVEF 33 ± 9%. Neither peak oxygen uptake (+0.25 ml/kg/min, 95% confidence interval [CI] -0.23 to +0.73, p = 0.3) nor LVEF (+0.5%, 95% CI -0.7 to 1.6, p = 0.4) changed with pacing but Minnesota Living with Heart Failure quality of life improved significantly (-3.7, 95% CI -7.1 to -0.3, p = 0.03). Seventy-six percent of patients preferred His bundle pacing-on and 24% pacing-off (p < 0.0001).

conclusionHis bundle pacing did not increase peak oxygen uptake but, under double-blind conditions, significantly improved quality of life and was symptomatically preferred by the clear majority of patients. Ventricular pacing delivered via the His bundle did not adversely impact ventricular function during the 6 months.

Indexed as

Cardiac Resynchronization TherapyHeart FailureBundle of HisCardiac Pacing, ArtificialCross-Over StudiesElectrocardiographyExercise ToleranceFemaleHumansMaleOxygenQuality of LifeStroke VolumeTreatment OutcomeVentricular Function, LeftOxygenAtrio-ventricular optimizationHeart failureHis bundle pacingPR prolongationRandomized controlled trial

Identifiers

PMID36404397
PMCPMC10946926
OpenAlexW4309517449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.